SCHEMBL7161647

SCHEMBL7161647

CCN(C=O)C(O)[C@H]1O[C@@H](n2cnc3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.63
▸ ADORA2B P29275 3/20 0.63
▸ TSHR P16473 3/20 0.61
▸ PMP22 Q01453 2/20 0.61
▸ SMN1; SMN2 Q16637 1/20 0.61
▸ TDP1 Q9NUW8 1/20 0.61
▸ CYP2C19 P33261 1/20 0.61
▸ THPO P40225 1/20 0.61
▸ ADORA3 P0DMS8 3/20 0.60
▸ ADORA1 P30542 2/20 0.60
▸ GAA P10253 1/20 0.60
▸ HTT P42858 1/20 0.60
▸ SIGMAR1 Q99720 1/20 0.60
▸ SLC29A1 Q99808 1/20 0.60
▸ RXFP1 Q9HBX9 1/20 0.60
▸ MEN1 O00255 1/20 0.60
▸ KMT2A Q03164 1/20 0.60
▸ TP53 P04637 1/20 0.60
▸ NFKB1 P19838 1/20 0.60
▸ HIF1A Q16665 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5685741 0.99 ADORA2A (0.61) ADORA2AADORA2BTSHRPMP22SMN1; SMN2
SCHEMBL6636036 0.86 ADORA2A (0.52) ADORA2AADORA2BADORA3ADORA1
SCHEMBL1298953 0.84 ADORA3 (0.74) ADORA2AADORA2BTSHRPMP22SMN1; SMN2
SCHEMBL9495200 0.82 ADORA2A (0.73) ADORA2AADORA2BTSHRPMP22SMN1; SMN2
SCHEMBL7744261 0.82 AHCY (0.46) ADORA2AADORA2B
SCHEMBL29877256 0.81 AHCY (0.61) ADORA2AADORA2BTSHRCYP2C19ADORA3
SCHEMBL177772 0.81 AHCY (0.61) ADORA2AADORA2BTSHRCYP2C19ADORA3
SCHEMBL28901883 0.81 AHCY (0.61) ADORA2AADORA2BTSHRCYP2C19ADORA3
SCHEMBL1320875 0.81 ADORA3 (0.64) TSHRPMP22TDP1ADORA3SLC29A1
SCHEMBL10579997 0.80 ADORA2A (0.67) ADORA2AADORA2BTSHRPMP22SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586413-B2 Methods and compositions for reducing ischemic injury of the heart by administering adenosine receptor agonists and antagonists THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES 2003-07-01 — — US disclosed
US-6329349-B1 CARDIOVASCULAR DISORDERS USING CARDIOPROTECTIVE AGENTS TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA 2001-12-11 — — US disclosed
Send feedback